lutein has been researched along with Parkinson Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghoreishy, SM; Jayedi, A; Mohammadi, H; Talebi, S; Travica, N | 1 |
| Araujo, SM; Barrientos, MS; Bortolotto, VC; De Carvalho, AS; Fernandes, EJ; Gonçalves, OH; Guerra, GP; Leimann, FV; Poetini, MR; Prigol, M; Ramborger, BP; Roehrs, R; Santos Musachio, EA | 1 |
| Essa, MM; Manivasagam, T; Nataraj, J; Thenmozhi, AJ | 1 |
| Bonnefoy, M; Drai, J; Kostka, T | 1 |
| Gorell, JM; Johnson, CC; Peterson, EL; Rybicki, BA; Sanders, K | 1 |
2 review(s) available for lutein and Parkinson Disease
| Article | Year |
|---|---|
Dietary Antioxidants and Risk of Parkinson's Disease: A Systematic Review and Dose-Response Meta-analysis of Observational Studies.
Topics: Anthocyanins; Antioxidants; Ascorbic Acid; beta Carotene; Humans; Lutein; Observational Studies as Topic; Parkinson Disease; Prospective Studies; Risk Factors; Vitamin E; Zinc | 2022 |
[Antioxidants to slow aging, facts and perspectives].
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Carotenoids; Cataract; Chronic Disease; Disease Models, Animal; Evidence-Based Medicine; Free Radicals; Humans; Lutein; Macular Degeneration; Neoplasms; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Vitamin E | 2002 |
3 other study(ies) available for lutein and Parkinson Disease
| Article | Year |
|---|---|
Exposure to lutein-loaded nanoparticles attenuates Parkinson's model-induced damage in Drosophila melanogaster: Restoration of dopaminergic and cholinergic system and oxidative stress indicators.
Topics: Acetylcholinesterase; Animals; Cholinergic Neurons; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Drosophila melanogaster; Lutein; Nanoparticles; Neurodegenerative Diseases; Neurotoxicity Syndromes; Oxidative Stress; Parkinson Disease | 2021 |
Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Topics: Animals; Antiparkinson Agents; Apoptosis; Apoptosis Regulatory Proteins; Behavior, Animal; Biomarkers; Dietary Supplements; Dopamine; Dopaminergic Neurons; Lutein; Male; Mice, Inbred C57BL; Mitochondria; Motor Activity; MPTP Poisoning; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Random Allocation; Substantia Nigra | 2016 |
Adult nutrient intake as a risk factor for Parkinson's disease.
Topics: Aged; Aged, 80 and over; Body Mass Index; Case-Control Studies; Dietary Fats; Eating; Energy Intake; Feeding Behavior; Female; Humans; Lutein; Male; Michigan; Middle Aged; Nutrition Surveys; Parkinson Disease; Risk Factors | 1999 |